Your body is accumulating cells that have stopped working. FOXO4-DRI helps clear them out.
There is a name for the cells that refuse to die. Scientists call them senescent cells. You probably call them aging.
Over time, your body accumulates cells that have stopped dividing but remain active, releasing a steady stream of inflammatory signals that disrupt surrounding tissue. This process, known as cellular senescence, is one of the most well-studied drivers of biological aging. It shows up as chronic fatigue, joint discomfort, slower recovery, hormonal decline, and a general sense that your body is not keeping up the way it used to.
FOXO4-DRI is a physician-supervised senolytic peptide designed to address this directly. It works at the cellular level to disrupt the mechanism that keeps senescent cells alive, allowing your immune system to clear them and make room for healthier function throughout the body.
At YoungerMeMD, FOXO4-DRI is part of the RestoreMe Suite, our program for patients who want to address aging at its root rather than manage symptoms after the fact.
Each accordion item below uses a patient-perspective label that expands to reveal the clinical explanation. Match accordion styling used across all suite pages.
I finally feel like my body is clearing out what it doesn’t need.
FOXO4-DRI works by disrupting the interaction between two proteins, FOXO4 and p53, that senescent cells rely on to resist programmed cell death. When that interaction is blocked, the senescent cell undergoes apoptosis, clearing the way for healthier tissue. The process is selective, meaning normal, functioning cells are not affected.
My inflammation markers came down and I didn’t change anything else.
Senescent cells continuously release inflammatory signals, a process called the senescence-associated secretory phenotype, or SASP. This low-grade inflammatory environment accelerates the aging of surrounding tissues. Reducing the senescent cell burden lowers that inflammatory load throughout the body, which is why many patients see improvements in labs, energy, and physical comfort after completing a FOXO4-DRI protocol.
My recovery from workouts and day-to-day stress is noticeably better.
When senescent cells accumulate in muscle and connective tissue, they impair the repair signals your body depends on after exertion. Clearing them restores a cleaner regenerative environment. Patients who combine FOXO4-DRI with an active lifestyle often report faster recovery, less soreness, and better overall physical resilience.
My doctor told me this could support my cardiovascular health long-term.
Research has shown that senescent endothelial cells, the cells that line blood vessels, are a significant contributor to vascular aging. FOXO4-DRI has demonstrated the ability to selectively clear these cells and improve vascular function in preclinical studies. While human clinical data is still emerging, the mechanistic case for cardiovascular benefit is well-supported in the research literature.
I wanted something that worked on aging at the cellular level, not just the surface.
FOXO4-DRI is one of a small number of compounds classified as senolytics, meaning it targets the root biology of aging rather than addressing downstream symptoms. For patients who have optimized hormones, nutrition, and lifestyle and still want to go deeper, senolytic therapy represents the next frontier of longevity medicine.
FOXO4-DRI may be a strong fit if you recognize yourself in any of the following:
FOXO4-DRI is not appropriate for everyone. Our Foundational Assessment allows Dr. Varano and his provider team to review your full health picture, including lab work, symptoms, and goals, before recommending any senolytic protocol.
FOXO4-DRI is a synthetic peptide that interrupts the survival signal inside senescent cells, the aged, dysfunctional cells that accumulate in your body over time. By disrupting this signal, the peptide allows those cells to undergo natural cell death, which is a normal and healthy process. This clears the way for better tissue function, reduced inflammation, and a more favorable environment for the rest of your cells to operate in.
FOXO4-DRI is administered via subcutaneous injection on a structured protocol determined by your provider. The protocol is typically short-course and intermittent, meaning it is not a daily ongoing therapy but rather a targeted reset administered at specific intervals. Your exact protocol will be built around your labs and health goals.
FOXO4-DRI has been studied in multiple preclinical models with consistent results showing selective clearance of senescent cells, reduced inflammatory markers, improved tissue function, and support for vascular health. Human clinical trials are still in earlier stages, which is why YoungerMeMD presents this as part of an emerging longevity protocol. Dr. Varano and his provider team will walk you through the current evidence and what it means for your specific situation.
Yes, and it often works best as part of a broader longevity protocol. FOXO4-DRI pairs well with Epitalon for comprehensive cellular age reset, with Thymosin Alpha-1 to address the inflammatory environment alongside senescent cell clearance, and with growth hormone peptides if you are also optimizing at the tissue regeneration level. Your provider will determine what combinations are appropriate based on your labs and goals.
Both are part of the RestoreMe Suite and both work at the level of cellular aging, but through different mechanisms. Epitalon focuses on telomere protection and biological age regulation through the pineal gland axis. FOXO4-DRI focuses on clearing cells that have already become senescent. Many patients benefit from both, and your provider may recommend using them together or in sequence depending on where you are in your health journey.
Because FOXO4-DRI works at the cellular level, the results are not always immediate or dramatic in the way a symptom-targeted therapy might feel. Most patients report gradual improvements in energy, physical recovery, and a sense of systemic resilience over weeks following a protocol. Repeat lab work and biomarker tracking are part of how Dr. Varano and his provider team evaluate progress and guide next steps.
Yes. All peptides used at YoungerMeMD, including FOXO4-DRI, are sourced from licensed, FDA-registered compounding pharmacies that meet USP 795 and 797 standards for sterility, potency, and safety. We do not source from research-only suppliers. Your safety and the integrity of your protocol depend on the quality of what goes into your body, and we take that seriously.
FOXO4-DRI is an emerging therapy that requires the right clinical context to use safely and effectively. At YoungerMeMD, every senolytic protocol is prescribed and monitored by Dr. Varano and his provider team based on your individual labs, health history, and goals. There is no one-size-fits-all approach here.
Every FOXO4-DRI patient starts with the same three-step foundation.
$599
Your starting point. Dr. Varano and his provider team review your full health picture, including comprehensive lab work, symptom history, and longevity goals. This is how we determine whether FOXO4-DRI is the right next step for you and what your protocol should look like.
$279/month
Ongoing access to Dr. Varano and his provider team, protocol management, prescription oversight, and the ability to layer additional programs into your plan as your needs evolve.
Coming Soon
Pricing varies based on your individualized protocol length and dosing cadence. Your provider will confirm program specifics and cost following your Foundational Assessment.
Senolytic therapy works best as part of a broader longevity protocol. These programs are the most common complements Dr. Varano and his provider team recommend alongside FOXO4-DRI.
FOXO4-DRI clears the cells that have stopped working. Epitalon supports the ones still dividing, protecting telomere length and regulating the biological clock at the pineal level. Together, they represent the most comprehensive cellular age-reset approach available. Many patients run these in sequence or as a combined RestoreMe protocol.
Learn about EpitalonChronic inflammation is one of the primary accelerators of cellular senescence. While FOXO4-DRI clears the senescent cells already present, Thymosin Alpha-1 helps regulate the immune and inflammatory environment that allowed them to accumulate. Pairing both addresses the condition at the source and helps sustain the results of your FOXO4-DRI protocol longer-term.
Learn about Thymosin Alpha-1Declining sex hormones directly accelerate senescent cell accumulation. Testosterone, estrogen, and progesterone each play protective roles at the cellular level. Patients who address both hormonal decline and senescent cell burden tend to see more complete and durable results than those pursuing either approach in isolation. If hormone optimization is not already part of your protocol, it is worth discussing at your assessment.
Learn about Hormone OptimizationGrowth hormone peptides like CJC-1295 and Ipamorelin signal your body to repair and rebuild. Those signals work better when the cells carrying them out are healthy and functional. A high senescent cell burden blunts the tissue response to GH optimization. FOXO4-DRI helps create the cleaner cellular environment your growth hormone protocol needs to perform at its best.
Learn about Peak PerformanceYour Foundational Assessment is where Dr. Varano and his provider team review your labs, your goals, and your full health picture to build a plan that makes sense for where you are right now.
Claim Your AssessmentFOXO4-DRI is not a shortcut. It is a targeted, physician-supervised protocol for patients who are serious about addressing cellular aging at the root. If you are ready to find out whether you are a candidate, start with the Foundational Assessment.
Fill up the form below to get started
Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.
Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.
DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.
Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.
Cardio Res-Q cardiac risk panel – lipid particle analysis, inflammation markers, and cardiovascular biomarkers beyond standard labs.
Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.
Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.
Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.
What It Evaluates
Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:
Conditions We Identify
